Impact of Population-Based Screening for Diabetes and Prediabetes Among 67-Year-Olds Using Point-of-Care HbA1c on Healthcare Ultilisation, Results from the VISP Cohort by Andersen JW, Høgh A, Lindholt JS, Søgaard R, Støvring H, Yderstræde KB, Sandbæk A, Dahl M

“…Pre- and post-screening healthcare utilization was analyzed, stratified by HbA1c levels: < 42 mmol/mol (normal), 42– 48 mmol/mol (pre-DM), and ≥ 48 mmol/mol (DM). …”
Get full text